• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前血清 CEA、CA19-9 和 CA125 水平对胃癌患者腹膜转移的预测价值。

Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma.

机构信息

Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Cancer Res Treat. 2004 Jun;36(3):178-81. doi: 10.4143/crt.2004.36.3.178. Epub 2004 Jun 30.

DOI:10.4143/crt.2004.36.3.178
PMID:20396541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2855081/
Abstract

PURPOSE

Peritoneal metastasis is a crucial factor for the prognosis in gastric cancer, but its diagnosis is difficult before laparotomy. This study analyzed the usefulness of diagnostic imaging and various tumor markers in the detection of peritoneal metastasis in gastric cancer.

MATERIALS AND METHODS

The sera from 768 patients with gastric cancer were measured for CEA, CA19-9 and CA125 levels using a commercial immunoradiometric assay. All the patients underwent diagnostic imaging with computed tomography (CT) and ultrasound (US) before laparotomy.

RESULTS

Preoperative levels of CEA, CA19-9 and CA125 were above the cut-off levels in 15.4%, 8.7% and 5.7% of all cases, respectively. Eighty-eight patients were diagnosed with peritoneal metastasis by laparotomy. CT and US revealed peritoneal dissemination in 15 of 88 patients (17%). Among the three tumor markers, CA19-9 and CA125 showed similar detection rates of peritoneal metastasis (37.5% and 38.6%, respectively). In particular, the serum CA125 levels showed the best sensitivity (38.6%), specificity (98.4%), and diagnostic accuracy (91.5%), and the highest odd ratio (24.46, 95% CI: 11.17 approximately 53.57) for predicting peritoneal metastasis among the markers tested. CEA did not add significant predictive information (p=0.471).

CONCLUSION

Preoperative serum CA19-9 and CA125 levels may provide a predictable value in determining peritoneal metastasis in patients with gastric cancer.

摘要

目的

腹膜转移是胃癌预后的关键因素,但在剖腹手术前很难诊断。本研究分析了诊断成像和各种肿瘤标志物在胃癌腹膜转移检测中的作用。

材料与方法

采用商业免疫放射分析试剂盒检测 768 例胃癌患者血清中 CEA、CA19-9 和 CA125 水平。所有患者均在剖腹手术前接受计算机断层扫描(CT)和超声(US)诊断成像。

结果

术前 CEA、CA19-9 和 CA125 水平分别高于所有病例的截止值 15.4%、8.7%和 5.7%。88 例患者通过剖腹术诊断为腹膜转移。CT 和 US 显示 88 例患者中有 15 例(17%)存在腹膜播散。在三种肿瘤标志物中,CA19-9 和 CA125 对腹膜转移的检测率相似(分别为 37.5%和 38.6%)。特别是血清 CA125 水平对预测腹膜转移具有最佳的敏感性(38.6%)、特异性(98.4%)和诊断准确性(91.5%),以及最高的优势比(24.46,95%CI:11.17~53.57)。CEA 没有增加显著的预测信息(p=0.471)。

结论

术前血清 CA19-9 和 CA125 水平可能为预测胃癌患者腹膜转移提供有价值的信息。

相似文献

1
Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma.术前血清 CEA、CA19-9 和 CA125 水平对胃癌患者腹膜转移的预测价值。
Cancer Res Treat. 2004 Jun;36(3):178-81. doi: 10.4143/crt.2004.36.3.178. Epub 2004 Jun 30.
2
Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.诊断性腹腔镜检查、血清CA125与胃癌腹膜转移
Endoscopy. 2002 Jul;34(7):569-74. doi: 10.1055/s-2002-33228.
3
Levels and Significance of Tumor Markers and Cytokines in Serum and Peritoneal Lavage Fluid of Patients with Peritoneal Metastasis of Gastric Cancer.胃癌腹膜转移患者血清和腹腔灌洗液中肿瘤标志物和细胞因子的水平及意义。
Biomed Res Int. 2022 Jun 2;2022:9528444. doi: 10.1155/2022/9528444. eCollection 2022.
4
Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.血清CA19-9、CEA、CA125和CA242在同步放化疗治疗的胰腺癌患者诊断及预后中的应用价值
Asian Pac J Cancer Prev. 2015;16(15):6569-73. doi: 10.7314/apjcp.2015.16.15.6569.
5
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.CEA、CA19-9、AFP 和 CA125 对早期胃癌的诊断和预后价值。
BMC Cancer. 2017 Nov 9;17(1):737. doi: 10.1186/s12885-017-3738-y.
6
[Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].[胃癌腹膜转移风险评估模型的建立及其预测价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25;20(1):47-52.
7
CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.CA72-4联合癌胚抗原(CEA)、糖类抗原125(CA125)和糖类抗原19-9(CA19-9)可提高胃癌早期诊断的敏感性。
Clin Chim Acta. 2014 Nov 1;437:183-6. doi: 10.1016/j.cca.2014.07.034. Epub 2014 Jul 30.
8
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.CEA、CA19-9、CA72-4和CA125在接受新辅助化疗的胃癌患者中的临床评估
World J Surg Oncol. 2014 Dec 29;12:397. doi: 10.1186/1477-7819-12-397.
9
Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination.CA125 和 CA72-4 在胃癌伴腹膜转移中的临床意义。
Gastric Cancer. 2012 Apr;15(2):154-61. doi: 10.1007/s10120-011-0091-8. Epub 2011 Sep 3.
10
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.血清肿瘤标志物癌胚抗原(CEA)、糖类抗原19-9(CA19-9)、糖类抗原125(CA125)、糖类抗原15-3(CA15-3)及组织多肽特异性抗原(TPS)在转移性乳腺癌中的诊断价值
Clin Chim Acta. 2017 Jul;470:51-55. doi: 10.1016/j.cca.2017.04.023. Epub 2017 Apr 27.

引用本文的文献

1
Targeting collagen to optimize cancer immunotherapy.靶向胶原蛋白以优化癌症免疫疗法。
Exp Hematol Oncol. 2025 Jul 29;14(1):101. doi: 10.1186/s40164-025-00691-y.
2
The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer.血浆MiR-9和MiR-106a水平与胃癌患者腹膜癌转移的发生有关。
BMC Cancer. 2025 Jul 1;25(1):1090. doi: 10.1186/s12885-025-14427-y.
3
Nomogram for predicting overall survival after curative gastrectomy using inflammatory, nutritional and pathological factors.基于炎症、营养和病理因素预测根治性胃切除术后总生存的列线图。
Clin Transl Oncol. 2024 Apr;26(4):1001-1011. doi: 10.1007/s12094-023-03340-0. Epub 2023 Nov 24.
4
Development and validation of a CT radiomics and clinical feature model to predict omental metastases for locally advanced gastric cancer.开发和验证 CT 放射组学和临床特征模型,以预测局部进展期胃癌的大网膜转移。
Sci Rep. 2023 May 25;13(1):8442. doi: 10.1038/s41598-023-35155-y.
5
Intraoperative Pathological Evaluation of Suspicious Peritoneal Nodules for Surgical Decision-making in Gastric Cancer.胃癌手术决策中可疑腹膜结节的术中病理评估。
J Gastrointest Surg. 2023 Aug;27(8):1545-1559. doi: 10.1007/s11605-023-05671-3. Epub 2023 Apr 14.
6
The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity.MUC16(CA125)生物标志物在肺癌中的潜在作用:一种神奇却又存在困境的生物标志物。
Diagnostics (Basel). 2022 Nov 29;12(12):2985. doi: 10.3390/diagnostics12122985.
7
Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis.分期腹腔镜检查中与胃癌腹膜癌转移相关的危险因素:一项系统评价和荟萃分析。
Front Oncol. 2022 Oct 28;12:955181. doi: 10.3389/fonc.2022.955181. eCollection 2022.
8
Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer.胶原蛋白家族作为癌症有前途的生物标志物和治疗靶点。
Int J Mol Sci. 2022 Oct 17;23(20):12415. doi: 10.3390/ijms232012415.
9
Predicting peritoneal carcinomatosis of gastric cancer: A simple model to exempt low-risk patients from unnecessary staging laparoscopy.预测胃癌腹膜转移:一种使低风险患者免于不必要分期腹腔镜检查的简单模型。
Front Surg. 2022 Jul 21;9:916001. doi: 10.3389/fsurg.2022.916001. eCollection 2022.
10
Construction of a Nomogram Model for Predicting Peritoneal Dissemination in Gastric Cancer Based on Clinicopathologic Features and Preoperative Serum Tumor Markers.基于临床病理特征和术前血清肿瘤标志物构建预测胃癌腹膜播散的列线图模型
Front Oncol. 2022 Jun 1;12:844786. doi: 10.3389/fonc.2022.844786. eCollection 2022.

本文引用的文献

1
The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.癌胚抗原(CEA)和/或糖类抗原19-9(CA19-9)在监测胃癌患者复发中的应用:一项前瞻性临床研究。
Gastric Cancer. 2003;6(3):142-5. doi: 10.1007/s10120-003-0240-9.
2
How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.如何解读有浆膜受累患者的血清CA 125水平?一个临床难题。
Oncology. 2003;65(1):1-6. doi: 10.1159/000071198.
3
Cancer antigen 125 associated with multiple benign and malignant pathologies.癌抗原125与多种良性和恶性病变相关。
Ann Surg Oncol. 2003 Mar;10(2):150-4. doi: 10.1245/aso.2003.05.015.
4
Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.诊断性腹腔镜检查、血清CA125与胃癌腹膜转移
Endoscopy. 2002 Jul;34(7):569-74. doi: 10.1055/s-2002-33228.
5
Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.胃癌患者血清CA72-4、CEA、TPA、CA19-9和CA125水平的比较及其与复发的相关性
Hepatogastroenterology. 2002 Jul-Aug;49(46):1157-60.
6
Japanese Classification of Gastric Carcinoma - 2nd English Edition -.日本胃癌分类 - 第二英文版 -
Gastric Cancer. 1998 Dec;1(1):10-24. doi: 10.1007/s101209800016.
7
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.癌胚抗原、CA 19-9和CA 72-4在胃癌中的预后价值。
Tumour Biol. 2001 Sep-Oct;22(5):318-22. doi: 10.1159/000050633.
8
Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.1297例胃癌患者术中灌洗用于细胞学检查
Am J Surg. 1999 Sep;178(3):256-62. doi: 10.1016/s0002-9610(99)00162-2.
9
Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma.血清CA 125水平作为胃癌患者腹膜播散的预测指标。
Cancer. 1998 Dec 15;83(12):2488-92. doi: 10.1002/(sici)1097-0142(19981215)83:12<2488::aid-cncr12>3.0.co;2-1.
10
Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer.胃癌中胰蛋白酶原表达与腹膜播散的早期检测
J Surg Oncol. 1998 Oct;69(2):71-5. doi: 10.1002/(sici)1096-9098(199810)69:2<71::aid-jso5>3.0.co;2-r.